Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Trisomy 17p is a rare chromosomal disorder caused by the presence of an extra copy of the short arm (p) of chromosome 17, which disrupts typical development. This condition leads to a wide range of clinical presentations, most commonly including developmental delays, intellectual disability, and specific physical dysmorphic features. What causes Trisomy 17p? Trisomy 17p occurs when an individual has three copies of the short arm of chromosome 17 instead of the usual two.
TL;DR: Trisomy 17p is a rare chromosomal disorder caused by the presence of an extra copy of the short arm (p) of chromosome 17, which disrupts typical development. This condition leads to a wide range of clinical presentations, most commonly including developmental delays, intellectual disability, and specific physical dysmorphic features.
Trisomy 17p occurs when an individual has three copies of the short arm of chromosome 17 instead of the usual two. This duplication creates a genetic imbalance, as the body receives an excess of instructions from the genes located on that chromosomal segment. While some cases of Trisomy 17p are inherited from a parent carrying a balanced translocation, many occur as a de novo (spontaneous) event during early embryonic development. Because the size and location of the duplicated segment can vary, the clinical severity of Trisomy 17p varies significantly between individuals.
The impact of Trisomy 17p is multisystemic, primarily affecting neurological and physical development. Common features often reported in medical literature include:
Trisomy 17p is considered an extremely rare chromosomal anomaly. Because the clinical presentation is broad and sometimes overlaps with other microduplication syndromes, it is likely underdiagnosed. There is no established gender or geographic predilection for Trisomy 17p, and symptoms typically manifest in the neonatal period or early childhood when developmental milestones are not met.
Unlike single-gene disorders, Trisomy 17p involves a large segment of DNA, affecting hundreds of genes simultaneously. It is differentiated from conditions like Smith-Magenis syndrome (which involves a deletion of a similar region on 17p) through high-resolution chromosomal microarray analysis (CMA). Geneticists use this testing to distinguish Trisomy 17p from other copy number variants that may present with similar physical traits.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.